Fezakinumab (Anti-IL-22)
Fezakinumab (Anti-IL-22) (A2440-GRP)
Products
Description
Fezakinumab (Anti-IL-22) is a monoclonal antibody targeting IL-22. It can be used for the research of inflammatory disease, such as psoriasis and rheumatoid arthritis. MW :145.5 KD.
Specifications
| Manufacturer | Selleck Chemicals LLC |
|---|---|
| Manufacturer Cat# | A2440 |
| Target | Interleukins |